Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB

Oncogene

Volumn 26, Issue 3, 2007, Pages 328-338

  Lallemand, C ^a   Blanchard, B ^a   Palmieri, M ^b   Lebon, P ^c   May, E ^a   Tovey, M G ^a  

^a INSTITUT ANDRÉ LWOFF   (France)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

IRF 1; IRF 3; NOXA; p53; Virus

Indexed keywords

CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOUBLE STRANDED RNA; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; PHOSPHOLIPASE A2; POLYPEPTIDE; PROTEIN NOXA; PROTEIN P53; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 3; VIRUS RNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MEASLES VIRUS; PRIORITY JOURNAL; RNA TRANSLATION; SENDAI VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

APOPTOSIS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CALCIUM; CARCINOMA, HEPATOCELLULAR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-3; LIVER NEOPLASMS; MEASLES VIRUS; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA VIRUSES; RNA, VIRAL; SENDAI VIRUS; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; TOLL-LIKE RECEPTOR 3; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VESICULAR STOMATITIS-INDIANA VIRUS;

MEASLES VIRUS; RNA VIRUSES; SENDAI VIRUS; SIMPLEXVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 33846330908     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209795     Document Type: Article

References (41)

1. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. (1999). Annu Rev Immunol 17: 189-220.
2. Bouker KB, Skaar TC, Fernandez DR, O'Brien KA, Riggins RB, Cao D et al. (2004). Cancer Res 64: 4030-4039.
3. Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC et al.(1997). J Exp Med 186: 967-972.
4. Chow WA, Fang JJ, Yee JK. (2000). J Immunol 164: 3512-3518.
5. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT et al. (2003). Nat Immunol 4: 491-496.
6. Geiss G, Jin G, Guo J, Bumgarner R, Katze MG, Sen GC. (2001). J Biol Chem 276: 30178-30182.
7. Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R et al. (2000). J Virol 74: 3781-3792.
8. Licata JM, Harty RN. (2003). Int Rev Immunol 22: 451-476.
9. Lin R, Heylbroeck C, Pitha PM, Hiscott J. (1998). Mol Cell Biol 18: 2986-2996.
10. Lyles DS. (2000). Microbiol Mol Biol Rev 64: 709-724.
11. Maggi Jr LB, Moran JM, Scarim AL, Ford DA, Yoon JW, McHowat J et al. (2002). J Biol Chem 277: 38449-38455.
12. Marques JT, Rebouillat D, Ramana CV, Murakami J, Hill JE, Gudkov A et al.(2005). J Virol 79: 11105-11114.
13. Martinson BD, Albert CJ, Corbett JA, Wysolmerski RB, Ford DA. (2003). J Lipid Res 44: 1686-1691.
14. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R et al.(2005). Nature 437: 1167-1172.
15. Miro-Mur F, Meiller A, Haddada H, May E. (2003). Oncogene 22: 5451-5456.
16. Moehler M, Blechacz B, Weiskopf N, Zeidler M, Stremmel W, Rommelaere J et al.(2001). Cancer Gene Ther 8: 158-167.
17. Moran JM, Buller RM, McHowat J, Turk J, Wohltmann M, Gross RW et al. (2005). J Biol Chem 280: 28162-28168.
18. Moro A, Santos A, Arana MJ, Perea SE. (2000). Biochem Biophys Res Commun 269: 31-34.
19. Munsch D, Watanabe-Fukunaga R, Bourdon JC, Nagata S, May E, Yonish-Rouach E et al. (2000). J Biol Chem 275: 3867-3872.
20. Nakagawa K, Yokosawa H. (2000). Eur J Biochem 267: 1680-1686.
21. Nakagawa K, Yokosawa H. (2002). FEBS Lett 530: 204-208.
22. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Science 288: 1053-1058.
23. Osborn L, Kunkel S, Nabel GJ. (1989). Proc Natl Acad Sci USA 86: 2336-2340.
24. Pestka S, Langer JA, Zoon KC, Samuel CE. (1987). Annu Rev Biochem 56: 727-777.
25. Pine R, Decker T, Kessler DS, Levy Jr DE, Darnell JE. (1990). Mol Cell Biol 10: 2448-2457.
26. Puthalakath H, Strasser A. (2002). Cell Death Differ 9: 505-512.
27. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A. (2004). J Biol Chem 279: 19712-19720.
28. Sanceau J, Hiscott J, Delattre O, Wietzerbin J. (2000). Oncogene 19: 3372-3383.
29. Sun Y, Leaman DW. (2005). J Biol Chem 280: 15561-15568.
30. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H et al. (2003). Nature 424: 516-523.
31. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW et al. (1996). Nature 382: 816-818.
32. Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S et al. (1998). Genes Cells 3: 29-37.
33. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. (2001). Annu Rev Immunol 19: 623-655.
34. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al.(2003). Science 302: 1036-1038.
35. Weaver BK, Ando O, Kumar KP, Reich NC. (2001). FASEB J 15: 501-515.
36. Weaver BK, Kumar KP, Reich NC. (1998). Mol Cell Biol 18: 1359-1368.
37. Williams SD, Ford DA. (2001). Am J Physiol Heart Circ Physiol 281: H168-H176.
38. Xie R, van Wijnen AJ, van Der Meijden C, Luong MX, Stein JL, Stein GS. (2001). J Biol Chem 276: 18624-18632.
39. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K et al. (2002). J Immunol 169: 6668-6672.
40. Yamamoto M, Takeda K, Akira S. (2004). Mol Immunol 40: 861-868.
41. Yoneyama M, Fujita T. (2004). Uirusu 54: 161-167.